Search results - ORA - Oxford University Research Archive

1 - 9 of 9

1

Journal article

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis

Shrimanker, R, Keene, O, Hynes, G, et al.
2019-07-12

2

Conference item

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Shrimanker, R, Pavord, I, Price, R, et al.
2018-12-01

3

Journal article

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.

Gunsoy, N, Cockle, S, Yancey, S, et al.
2017-12-01

4

Journal article

Biomarkers for severe eosinophilic asthma.

Yancey, S, Keene, O, Albers, F, et al.
2017-12-01

5

Journal article

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma

Yancey, S, Ortega, H, Keene, O, et al.
2016-01-01

6

Journal article

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Pavord, I, Korn, S, Howarth, P, et al.
2012-08-01

7

Journal article

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Bel, E, Wenzel, SE, Thompson, P, et al.
2014-09-01

8

Journal article

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.

Ortega, H, Yancey, S, Mayer, B, et al.
2016-05-01

9

Journal article

Mepolizumab treatment in patients with severe eosinophilic asthma.

Ortega, H, Liu, M, Pavord, I, et al.
2014-09-01

TO TOP